Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohorts

Cancer Cell. 2023 Jul 10;41(7):1381. doi: 10.1016/j.ccell.2023.06.002.
No abstract available

Publication types

  • Published Erratum